Newest A-Z
ADAPT-HEAT - Adaptation of drug therapy during hot seasons
>Federal Joint Committee | Innovation Fund
PharmacotherapyPlanetary Health
TOP – Transsectoral optimization of patient safety
>Federal Joint Committee | Innovation Fund
PharmacotherapySupply curves
BARMER Pharmaceutical Report
>BARMER
PharmacotherapyClaims data
EVITA – Evidence-based multi-medication program
>Federal Joint Committee | Innovation Fund
PharmacotherapyDevelopment of Guidelines
Medication Catalogue
>National Association of Statutory Health Insurance Physicians
PharmacotherapyLiterature Research
K-APAT – Outpatient parenteral antibiotic therapy in the Cologne metropolitan region
>Federal Joint Committee | Innovation Fund
PharmacotherapyData preparation
Estimation of the prevalence and incidence of hyperkinetic disorder and its treatment
>Own resources
PharmacotherapyDisease incidence
AdAM – Application of digitally supported pharmaceutical therapy
>Federal Joint Committee | Innovation Fund
PharmacotherapyData infrastructure
Analysis of the prescription of Valproat and related substances over time
>Federal Institute for Drugs and Medical Devices BfArM
PharmacotherapyClaims data
Determination of the SHI target population for the indication diabetes mellitus type 2 using SHI routine data
>IQWiG
PharmacotherapyClaims data
Chronic rheumatic diseases in women of childbearing age
>UCB Pharma GmbH
PharmacotherapyStatistical Analyses
Operationalisation and frequency estimation of a statin intolerance
>Sanofi-Aventis Deutschland GmbH
PharmacotherapyStatistical Analyses
CONTRIBUTE - Switch from OFF-Label & Best Supportive Care to approved therapies in various autoimmune diseases: Implementation, impact on disease progression and adverse events
>Federal Joint Committee | Innovation Fund
PharmacotherapyStatistical Analyses
METHODS
TOPICS
DATA
